MStrive’s Patient-Centric Care Model Redefines the Kidney Care Experience
Patients with kidney disease deserve more coordinated, holistic and compassionate care. Strive aims to revolutionize the patient
We are modernizing the delivery of healthcare to Medicare patients with End-Stage Renal Disease
Renal Payer Solutions, LLC (RPS) has been developed to address the significant treatment issues for individuals with End-Stage Renal Disease (ESRD). The Company is a Medicare Advantage Prescription Drug Plan (MAPD) Special Needs Plan caring for individuals with End Stage Renal Disease. Treatment of ESRD is demanding, multifaceted and complex, requiring strict patient adherence to treatment protocols in order to achieve favorable health outcomes and satisfactory quality of life.
Nonadherence to treatment among dialysis patients is widely recognized in the renal community as an important contributor to suboptimal treatment and poorer health outcomes. The results of nonadherence to treatment are increased and avoidable medical costs. Dialysis patients face intricate challenges in consistently maintaining their prescribed routine of limiting fluid intake, maintaining dietary requirements, attending regular hemodialysis sessions, and taking multiple medications. Nonadherence can lead to avoidable hospitalization, adverse health effects, or even death. As an MAPD Health Plan, RPS is a business that will support the member, caregivers, and providers of Medicare beneficiaries with ESRD, helping all to live an improved life, reduce avoidable healthcare expenses and enhance the overall well-being of the Health Plan’s members.
The MAPD market, in general, is extremely competitive, and entering the market can be challenging. With the passing of the 21st-century CURE’s act in 2021, the federal government is pushing to make ESRD more efficient and reduce the cost of care. In 2018, there were 519,000 individuals receiving dialysis services in the USA, with the majority of those patients insured through Medicare FFS. That number is increasing by about 3% per year. Developing a strong MAPD SNP Plan for Medicare beneficiaries with ESRD is attractive to patients, caregivers, and providers as patients and providers receive more support of their care than in the Medicare fee-for-service system, patient cost of care is reduced, and providers will have the opportunity to share in savings to the overall cost of care. The ESRD market is one of the few Medicare populations that have an opportunity to grow without significant initial marketing and enrollment costs.
Renal Payer Solutions, LLC is a health plan company that will offer managed care insurance as well as manage and provide services in support of specialty services managed care programs for renal dialysis members. RPS will contract with Payors and governmental entities on a monthly capitated payment and in exchange RPS will provide all covered services for eligible members. RPS establishes contracts with health care providers to provide or arrange covered services on a captitated or fee-for-service basis for enrolled members. The health care providers include IPAs. RPS provides or arranges for management services to be provided for the day-to-day operations of the IPAs in exchange for a management fee under a management services contract. RPS otherwise operates the managed care enterprise, including utilization review and related programs, and coordinates the care provided to patients assigned as members to it by the various payors. RPS intends to operate initially in four states, California, Arizona, Nevada, and Texas, and plans to operate more broadly in the future.
The Founders of the Company are a formidable team possessing varying skills, who are uniquely qualified to deliver company vision and goals. Jerome Tannenbaum, MD is an experienced Nephrologist and Dialysis operator, who has successfully grown and operated three national dialysis companies. He has developed an innovative and supportive approach to allow for successful home hemodialysis service. Jeffrey Davis and Jay Davis each have nearly 40 years of experience each developing and managing Health Plans, with experience managing populations with difficult and complex medical and behavioral conditions. Michael Wong, DO has experience growing and managing medical groups and IPAs as well as a long history of providing patient care. A team is being developed with diverse experience in the medical delivery of complex populations to support the company
Dr Mike Wong, Chief Strategy Officer, (949) 701-1133, drmhwong@gmail.com Renal Payer Solutions, 19700 Fairchild Road, Suite 230, Irvine, CA 92612
Our high-touch clinical team, powered by predictive analytics, identifies patients early and cares for the whole patient from Chronic Kidney Disease (CKD) through End Stage Renal Disease (ESRD), managing patients’ co-morbid conditions and addressing social and behavioral needs. Strive Health is a turn-key solution for your kidney disease population.
Patients with kidney disease deserve more coordinated, holistic and compassionate care. Strive aims to revolutionize the patient
corporis earum eum consequatur autem facere aliquid dolores sint rerum laudantium officiis molestias? Cum, dignissimos nemo
Lorem ipsum, dolor sit amet consectetur adipisicing elit. Commodi tempora vitae quis quasi fuga recusandae.
Dr. Mike Wong at mwong@renalpayer.com
Corporate Headquarters 511 Union Street, Suite 1800 Nashville, TN 37219
19700 Fairchild Rd, Suite 230 Irvine, CA 92612